N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.
about
Science review: natriuretic peptides in critical illnessHigh-sensitivity troponin T: a biomarker for diuretic response in decompensated heart failure patients.N-terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF).Early neurohormonal effects of trandolapril in patients with left ventricular dysfunction and a recent acute myocardial infarction: a double-blind, randomized, placebo-controlled multicentre study.Towards a blood test for heart failure: the potential use of circulating natriuretic peptides.Natriuretic peptides in the pathophysiology of congestive heart failure.Cardiac natriuretic peptides--hope or hype?Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology.Natriuretic peptides in relation to the cardiac innervation and conduction system.Ventricular dilatation in the absence of ACE inhibitors: influence of haemodynamic and neurohormonal variables following myocardial infarctionNeuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group.Left ventricular dysfunction, natriuretic peptides, and mortality in an urban populationN-terminal proatrial natriuretic peptide correlates with systolic dysfunction and left ventricular filling pattern in patients with idiopathic dilated cardiomyopathy.Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practiceMyocardial performance and its acute response to angiotensin II infusion in fetal sheep adapted to chronic anemia.Determinants of natriuretic peptide production by the heart: basic and clinical implications.Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart diseasePlasma proatrial natriuretic factor (1-98) concentration after myocardial infarction: relation to indices of cardiac and renal functionHormonal and renal differences between low dose and high dose angiotensin converting enzyme inhibitor treatment in patients with chronic heart failure.Natriuretic peptides and cyclic guanosine 3',5'-monophosphate in asymptomatic and symptomatic left ventricular dysfunction.Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment.Brain natriuretic peptide predicts mortality in the elderly.Assessment of the left atrial volume index and plasma NT-proANP level in patients with acute ST-elevation myocardial infarction.Decompensated heart failure is associated with reduced corin levels and decreased cleavage of pro-atrial natriuretic peptide.Natriuretic peptides: Diagnostic and therapeutic use.Atrial natriuretic peptide and its potential role in pharmacotherapy.Comparison of N-terminal pro B-natriuretic Peptide and echocardiographic indices in patients with mitral regurgitation.Neuroendocrine activation after myocardial infarction: causes and consequences.The prognostic value of atrial and brain natriuretic peptides, troponin I and C-reactive protein in patients with sepsis.The role of the neurohormonal system in heart failure.Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography.Relations between medical history, clinical findings and plasma N-terminal proatrial natriuretic peptide in patients in primary health care.Effects of dose-intensive chemotherapy and radiotherapy on serum n-terminal proatrial natriuretic peptide in high-risk breast cancer patients.Blood levels of atrial natriuretic peptide, endothelin, cortisol and ACTH in patients undergoing coronary artery bypass grafting surgery with cardiopulmonary bypass.Pronatriuretic peptide is a sensitive marker of the endocrine function of teleost heart.Heart rate reduction by zatebradine reduces infarct size and mortality but promotes remodeling in rats with experimental myocardial infarction.Biochemical analysis of neutral endopeptidase activity reveals independent catabolism of atrial and brain natriuretic peptide.A direct comparison of the natriuretic peptides and their relationship to survival in chronic heart failure of a presumed non-ischaemic origin.Relation of ANP and BNP to their N-terminal fragments in fetal circulation: evidence for enhanced neutral endopeptidase activity and resistance of BNP to neutral endopeptidase in the fetus.Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation.
P2860
Q24799740-BC23BB3B-1239-4262-A667-C5D09C1741C5Q30854596-AAC35F27-92CD-4E63-AC4C-61DC08157BFAQ30908647-FF273E9E-4051-4FA6-8C51-8D57767966EBQ31863980-8B089AFD-DBAA-4438-A499-9FC4C793704CQ33962030-D0E84156-6F05-4335-8DC7-87B74509DEACQ34027488-E71DDA17-E690-4F7F-81F0-94AF6A28D5AAQ34207401-E3C3621F-9D08-4F7C-9941-7105C8798B3BQ34544890-C7822D2A-2E44-4582-B709-75AE6B2AC7F6Q34845237-C6BFEA39-F934-4C19-8992-73EA7AC7CA9AQ35370392-09DB4DA7-E3D7-49CE-A498-97CD3CC81E81Q35370704-717E4D5A-41AB-4C33-9BE9-7F7E0451E8B4Q35380181-99013967-27E2-480E-8B5A-2A8D3BD02F93Q35566711-15647DCD-532C-4068-9DF3-2DF2C02B97BBQ35843114-371EDBC9-D58A-4404-9A7C-F4B79DFD9D11Q35931078-A62EC268-ADED-442C-B5E6-17C6C32D70B7Q36317209-D26E06C7-2F46-4319-8AFD-0B79AC89A347Q36694171-B3EDB441-2D1E-4FFD-812F-C1F2645A6C05Q36820431-7A78E46E-F0C4-4ABE-87F3-6B6263C686AEQ36832421-B3401455-9161-4ED9-ADCF-4D9866B0420BQ36834363-2435B5BF-0E8B-48BD-B70F-986ABD911504Q36835952-75E7936B-FCE9-4F38-9BA1-D382572E428FQ36841331-7398F97D-2CA8-46AC-970F-F6ABBC736C88Q37023112-DF1F4284-26E1-4E27-90C0-78CE549CDF60Q37343367-BE3614C7-AD09-4F50-8409-99D6EA6CE1E0Q39581832-57FAEFB4-FA36-4591-A105-6F33FBACAEC8Q40518014-6BF71BCF-907B-45C6-B604-E9D440F1C576Q41141219-2F4AFCC0-E5C0-4ADC-AEBC-3D9445897C7EQ41284840-F89A624E-E17B-42D6-9413-EBC7F59616FEQ41777501-4D3A0D10-AA9C-4405-810D-BD4FA6341DC9Q43018678-59DED9FD-1FFF-4068-87FC-0BB14CFF6EF3Q43605703-5893DC92-DC29-43C4-B26A-50FDE09C2F92Q43621185-7DED79F2-519E-4FD5-85F3-621B6CAAC47FQ43740854-292A6CFF-7923-4B2A-8CDA-D17D76FA14E5Q43838673-13CAE9F2-FC6B-4DD2-AE8D-D0A8D2B4F771Q43908145-1187870D-409D-49E7-9BB3-625BF978C4DBQ44799612-AD4578B1-BD9F-44DD-A587-BE77239629F8Q44854138-685A6042-ABCA-4C1F-9B2A-E24816D92ED8Q46514949-5C26E0C8-49C1-4CEA-9D5F-6F947BD71A72Q47712431-72B69E2C-57F1-4B11-9307-3D9BCEBDCAE9Q48378465-282D01C7-2DF8-4270-9D0C-26AEB5AB2D9A
P2860
N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
N-terminal proatrial natriuret ...... s after myocardial infarction.
@en
N-terminal proatrial natriuret ...... s after myocardial infarction.
@nl
type
label
N-terminal proatrial natriuret ...... s after myocardial infarction.
@en
N-terminal proatrial natriuret ...... s after myocardial infarction.
@nl
prefLabel
N-terminal proatrial natriuret ...... s after myocardial infarction.
@en
N-terminal proatrial natriuret ...... s after myocardial infarction.
@nl
P2093
P356
P1433
P1476
N-terminal proatrial natriuret ...... is after myocardial infarction
@en
P2093
J L Rouleau
J de Champlain
M O Arnold
P304
P356
10.1161/01.CIR.89.5.1934
P407
P577
1994-05-01T00:00:00Z